Literature DB >> 9878258

A long terminal repeat of the human endogenous retrovirus ERV-9 is located in the 5' boundary area of the human beta-globin locus control region.

Q Long1, C Bengra, C Li, F Kutlar, D Tuan.   

Abstract

Transcription of the human beta-like globin genes in erythroid cells is regulated by the far-upstream locus control region (LCR). In an attempt to define the 5' border of the LCR, we have cloned and sequenced 5 kb of new upstream DNA. We found an LTR retrotransposon belonging to the ERV-9 family of human endogenous retroviruses in the apparent 5' boundary area of the LCR. This ERV-9 LTR contains an unusual U3 enhancer region composed of 14 tandem repeats with recurrent GATA, CACCC, and CCAAT motifs. This LTR is conserved in human and gorilla, indicating its evolutionary stability in the genomes of the higher primates. In both recombinant constructs and the endogenous human genome, the LTR enhancer and promoter activate the transcription of cis-linked DNA preferentially in erythroid cells. Our findings suggest the possibility that this LTR retrotransposon may serve a relevant host function in regulating the transcription of the beta-globin LCR. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878258     DOI: 10.1006/geno.1998.5608

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  27 in total

Review 1.  Chromatin modification by DNA tracking.

Authors:  A Travers
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Intergenic transcription in the human beta-globin gene cluster.

Authors:  K E Plant; S J Routledge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells.

Authors:  Jianhua Ling; Wenhu Pi; Roni Bollag; Shan Zeng; Meral Keskintepe; Hatem Saliman; Sanford Krantz; Barry Whitney; Dorothy Tuan
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  The ERV-9 LTR enhancer is not blocked by the HS5 insulator and synthesizes through the HS5 site non-coding, long RNAs that regulate LTR enhancer function.

Authors:  Jianhua Ling; Wenhu Pi; Xiuping Yu; Chikh Bengra; Qiaoming Long; Huaqian Jin; Andreas Seyfang; Dorothy Tuan
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

5.  Recruitment of transcription complexes to the beta-globin gene locus in vivo and in vitro.

Authors:  Karen F Vieira; Padraic P Levings; Meredith A Hill; Valerie J Crusselle; Sung-Hae Lee Kang; James Douglas Engel; Jörg Bungert
Journal:  J Biol Chem       Date:  2004-09-22       Impact factor: 5.157

6.  Long-range function of an intergenic retrotransposon.

Authors:  Wenhu Pi; Xingguo Zhu; Min Wu; Yongchao Wang; Sadanand Fulzele; Ali Eroglu; Jianhua Ling; Dorothy Tuan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

7.  The human beta-globin locus control region can silence as well as activate gene expression.

Authors:  Yong-Qing Feng; Renaud Warin; Taihao Li; Emmanuel Olivier; Arnaud Besse; Amanda Lobell; Haiqing Fu; Chii Mei Lin; Mirit I Aladjem; Eric E Bouhassira
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

8.  Highly restricted localization of RNA polymerase II within a locus control region of a tissue-specific chromatin domain.

Authors:  Kirby D Johnson; Jeffrey A Grass; Changwon Park; Hogune Im; Kyunghee Choi; Emery H Bresnick
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 9.  Retroelements and their impact on genome evolution and functioning.

Authors:  Elena Gogvadze; Anton Buzdin
Journal:  Cell Mol Life Sci       Date:  2009-08-02       Impact factor: 9.261

10.  Cell type specificity of chromatin organization mediated by CTCF and cohesin.

Authors:  Chunhui Hou; Ryan Dale; Ann Dean
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.